slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,44 USD | -8,86% | -2,70% | -58,62% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 2,95 mln. 3,23 mln. 3,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 10 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,11% |
Recentste transcriptie over Altamira Therapeutics Ltd.
1 dag | -8,86% | ||
1 week | -2,70% | ||
Lopende maand | -30,43% | ||
1 maand | -16,76% | ||
3 maanden | -36,84% | ||
6 maanden | -56,36% | ||
Lopend jaar | -58,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01-11-21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01-03-18 |
Mats Blom
BRD | Director/Board Member | 59 | 01-04-17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1,44 | -8,86% | 3 000 617 |
23-04-24 | 1,58 | +12,86% | 110 808 |
22-04-24 | 1,4 | -0,99% | 107 242 |
19-04-24 | 1,414 | -5,73% | 46 743 |
18-04-24 | 1,5 | +1,35% | 24 812 |
slotkoers Nasdaq, 24 april 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-58,62% | 3,23 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,46% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,00% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |